These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 34669431)

  • 21. The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.
    Yaklai K; Pattanakuhar S; Chattipakorn N; Chattipakorn SC
    Am J Chin Med; 2021; 49(2):285-314. PubMed ID: 33622207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions.
    Ghaffari P; Shoaie S; Nielsen LK
    J Transl Med; 2022 Apr; 20(1):173. PubMed ID: 35410233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut-Brain Axis and Behavior.
    Martin CR; Mayer EA
    Nestle Nutr Inst Workshop Ser; 2017; 88():45-53. PubMed ID: 28346923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of gut microbiota via the gut-liver-brain axis in digestive diseases.
    Ding JH; Jin Z; Yang XX; Lou J; Shan WX; Hu YX; Du Q; Liao QS; Xie R; Xu JY
    World J Gastroenterol; 2020 Oct; 26(40):6141-6162. PubMed ID: 33177790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The critical role of gut-brain axis microbiome in mental disorders.
    Basiji K; Sendani AA; Ghavami SB; Farmani M; Kazemifard N; Sadeghi A; Lotfali E; Aghdaei HA
    Metab Brain Dis; 2023 Dec; 38(8):2547-2561. PubMed ID: 37436588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Neuroendocrine signalling pathways along the microbiota-gut-brain axis in functional gut disorders.
    Giron MC; Baj A; Giaroni C
    Front Endocrinol (Lausanne); 2022; 13():996382. PubMed ID: 36213279
    [No Abstract]   [Full Text] [Related]  

  • 29. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
    Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Brain-Gut-Microbiome Axis.
    Martin CR; Osadchiy V; Kalani A; Mayer EA
    Cell Mol Gastroenterol Hepatol; 2018; 6(2):133-148. PubMed ID: 30023410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction.
    Zheng H; Zhang C; Zhang J; Duan L
    Protein Cell; 2023 Oct; 14(10):726-742. PubMed ID: 37074139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiome in disorders of gut-brain interaction.
    Kraimi N; Ross T; Pujo J; De Palma G
    Gut Microbes; 2024; 16(1):2360233. PubMed ID: 38949979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis.
    Baj A; Moro E; Bistoletti M; Orlandi V; Crema F; Giaroni C
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.
    Mishima Y; Ishihara S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Diet-Microbiome Interaction in Gastrointestinal Disorders and Strategies to Modulate Them with Microbiome-Targeted Therapies.
    Jadhav A; Bajaj A; Xiao Y; Markandey M; Ahuja V; Kashyap PC
    Annu Rev Nutr; 2023 Aug; 43():355-383. PubMed ID: 37380178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.
    Ringel Y
    Gastroenterol Clin North Am; 2017 Mar; 46(1):91-101. PubMed ID: 28164856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.
    Tang H; Chen X; Huang S; Yin G; Wang X; Shen G
    Rev Neurosci; 2023 Oct; 34(7):763-773. PubMed ID: 36757367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global research trends in the microbiome related to irritable bowel syndrome: A bibliometric and visualized study.
    Zyoud SH; Smale S; Waring WS; Sweileh W; Al-Jabi SW
    World J Gastroenterol; 2021 Apr; 27(13):1341-1353. PubMed ID: 33833487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.